ENOV
Enovis Corporation
NYSE · usd
Enovis Corporation (ENOV) trades at $27.68 (+0.14%) as of 7:30:07 PM EST on Nov 13, 2026, +43.05% over the past month. Market cap is $1.59B, with 7.3 days to cover in short interest.
Stock performance
How Enovis Corporation (ENOV) stock has performed from one day to one year, with its 52-week range.
- 1D
- +0.14%
- 1W
- +1.91%
- 1M
- +43.05%
- YTD
- +3.90%
- 1Y
- -7.70%
- 52-wk range
- $16.70 – $31.67
Key statistics
Today's trading snapshot for ENOV: day range, open, previous close, volume and market cap.
- Day range
- $27.63 – $28.89
- Open
- $28.65
- Prev close
- $27.64
- Volume
- 1.21M
- Market cap
- $1.59B
- Shares out
- 57.69M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Enovis Corporation: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 0.69
- P/B
- 1.07
- P/FCF
- 22.92
- ROE
- -35.3%
- ROA
- -14.1%
- Debt/Equity
- 0.84
- Div yield
- 0.00%
As of Nov 12, 2026
8-K filings
Material corporate events Enovis Corporation has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 5, 2026
On November 5, 2026, the Company issued a press release reporting financial results for the third quarter ended October 2, 2026.
- Acquisition agreementSep 1, 2026
On August 31, 2026, Enovis Corporation (the "Company") entered into a binding offer to acquire eCential Robotics SAS ("eCential")... Under the terms of the agreement, the Company will acquire eCential based on an enterprise value of approximately €155,000,000, subject to certain adjustments, which corresponds to up-front consideration of approximately €176,000,000 in cash to be paid to eCential shareholders upon the closing of the acquisition, and, to the extent that certain milestones are achieved, up to an additional €35,000,000 in cash.
- Executive compensation changeMay 19, 2026
The 2020 Plan Amendment (i) authorizes an additional 3,650,000 shares of the Company's common stock, par value $0.001 per share, for issuance under the 2020 Omnibus Incentive Plan and (ii) increases the maximum aggregate dollar value of equity-based awards and cash compensation that may be granted to any Outside Director from $350,000 to $750,000.
- Executive compensation changeDec 15, 2025
During the Transition Period, Ms. Lang will continue to receive her current base salary for a period of six months, after which her base salary will be reduced by up to 50% for the remainder of the Transition Period. Ms. Lang will remain eligible to participate in the Company benefit plans in which she currently participates, including the Company's annual incentive plan.
- Credit facilityDec 10, 2025
The Amended Credit Agreement provides for a revolving credit facility of up to $1.1 billion (the "Revolving Facility" and the loans thereunder, the "Revolving Loans") and a term loan facility of $700.0 million (the "Term Loan Facility" and the loans thereunder, the "Term Loans"). The Third Amendment extended the maturity date for all outstanding Revolving Loans and Term Loans to December 8, 2030.
ENOV short interest
How heavily ENOV is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.3
- Short interest
- 10.56M
- Avg volume
- 1.45M
As of · reported to FINRA twice monthly.
ENOV news
The latest news and headlines about Enovis Corporation (ENOV).
- Enovis (ENOV) Q3 Earnings and Revenues Beat EstimatesneutralZacks Investment Research· Nov 5, 2026
- Enovis to Host Second Quarter 2026 Results Conference Call on August 6thneutralGlobeNewswire Inc.· Jul 17, 2026
- 4 Top Growth Stocks Worth Buying Under $100 TodaypositiveThe Motley Fool· Jul 3, 2026
- ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?neutralThe Motley Fool· May 22, 2026
- Enovis to Host First Quarter 2026 Results Conference Call on May 7thpositiveGlobeNewswire Inc.· Apr 10, 2026
Frequently asked questions
What is the Enovis Corporation (ENOV) stock price today?
Enovis Corporation (ENOV) is trading at $27.68 (+0.14% on the day) as of 7:30:07 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Enovis Corporation?
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy.
What is the short interest in ENOV?
As of Oct 30, 2026, ENOV has 10.56M shares short and 7.3 days to cover.
What exchange is ENOV listed on?
Enovis Corporation (ENOV) trades on NYSE in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.
Build with AI
Build an analysis of ENOV with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ENOV analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.